Latest Compliance News

Meteoric Resources NL has voluntarily suspended trading of its shares on the ASX pending a key announcement addressing media speculation about its Preliminary License approval process.

Prophecy International Holdings reports a modest revenue dip and net loss in FY25, cancels its Complexica merger, and pivots to AI-driven product innovation and cost control.

VHM Limited has launched a non-underwritten Share Purchase Plan offering eligible shareholders in Australia and New Zealand the chance to invest up to $30,000 at $0.35 per share, a significant discount to recent trading prices. The capital raised will support key development stages of the Goschen Project ahead of a final investment decision in early 2026.

Riedel Resources has initiated a significant diamond drilling campaign at its Kingman Gold Project in Arizona, aiming to expand its high-grade gold and silver resource. The fully funded program is set to deliver initial assay results in January 2026.

Renergen Limited and ASP Isotopes Inc. have secured crucial regulatory approvals and agreed to extend the deadline for completing their Scheme of Arrangement to January 2026, signaling steady progress in their strategic partnership.

Sabre Resources has reported significant rare earth and critical metal anomalies at its Dingo Project in the Northern Territory, highlighting promising concentrations of key magnet metals Neodymium and Praseodymium. The company plans follow-up drilling to further evaluate these discoveries.

QGold Pty Ltd has initiated an unconditional on-market takeover offer for all remaining shares of Venus Metals Corporation at $0.17 per share, aiming to consolidate control by mid-January 2026.

Thunderbird Resources has completed its acquisition of LM2 Metals, gaining full ownership of the Springfield Gold Deposit in central NSW and issuing over 28 million shares as part of the deal.

Hexima Limited reveals plans to return capital to shareholders and restructure its board following the closure of its main clinical program and prolonged ASX trading suspension.

SomnoMed Limited reported a robust FY25 with revenue surpassing guidance and a landmark FDA clearance for its Rest Assure® oral device, setting the stage for sustained growth in oral appliance therapy.

SDI Limited reported stable FY25 revenue with improved margins and advancing Montrose project, while regional sales showed mixed results.

SDI Limited reported a steady FY2025 with a slight profit increase, driven by growth in aesthetic and whitening products and the launch of its new amalgam replacement, Stela. The company also announced plans for a new factory to boost production capacity.